Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 44 results
Filters: First Letter Of Last Name is B  [Clear All Filters]
Found 44 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

B

Badal-Faesen S, Firnhaber C, Kendall MA, et al. "Impact of Larger Sputum Volume on XpertMTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis." J Clin Med. 2017;6(8).
Bakshi RP, Hamzeh F, Frank I, et al. "Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients." AIDS Res. Hum. Retroviruses. 2007;23(11):1360-5.
Balagopal A, Gupte N, Shivakoti R, et al. "Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort." Open Forum Infect Dis. 2016;3(3):ofw118.
Balagopal A, Asmuth DM, Yang W-T, et al. "Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study." J. Acquir. Immune Defic. Syndr.. 2015;70(2):163-71.
Bar KJ, Sneller MC, Harrison LJ, et al. "Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption." N. Engl. J. Med.. 2016;375(21):2037-2050.
Bartha I, Carlson JM, Brumme CJ, et al. "A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control." Elife. 2013;2:e01123.
Bartlett JA, Chen S-S, Quinn JB. "Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview." HIV Clin Trials. 2007;8(4):221-6.
Bartlett JA, Ribaudo HJ, Wallis CL, et al. "Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings." AIDS. 2012;26(11):1345-54.
Basham RJ, Richardson DM, Sutcliffe CB, Haas DW. "Effect of HIV-1 infection on human DNA yield from saliva." HIV Clin Trials. 2009;10(4):282-5.
Bedimo R, Kang M, Tebas P, et al. "Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients." AIDS Res. Hum. Retroviruses. 2016;32(4):325-8.
Bednar MM, Hauser BM, Zhou S, et al. "Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation." J. Infect. Dis.. 2016;214(3):403-7.
Bednasz CJ, Venuto CS, Ma Q, et al. "Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants." Ther Drug Monit. 2017;39(6):596-603.
Bednasz CJ, Sawyer JR, Martinez A, et al. "Recent advances in management of the HIV/HCV coinfected patient." Future Virol. 2015;10(8):981-997.
Behler CM, Vittinghoff E, Lin F, et al. "Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects." Clin. Infect. Dis.. 2007;44(10):1375-83.
Benson CA, Vaida F, Havlir DV, et al. "A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086." J. Infect. Dis.. 2006;194(9):1309-18.
Besson GJ, Lalama CM, Bosch RJ, et al. "HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy." Clin. Infect. Dis.. 2014;59(9):1312-21.
Bhagwat P, Ofotokun I, McComsey GA, et al. "Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes." Antivir. Ther. (Lond.). 2017;22(7):577-586.
Bhasin S, Parker RA, Sattler F, et al. "Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity." J. Clin. Endocrinol. Metab.. 2007;92(3):1049-57.
Bisson GP, Ramchandani R, Miyahara S, et al. "Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults." AIDS. 2017;31(16):2217-2225.
Blackard JT, Kang M, J St Clair B, et al. "Viral factors associated with cytokine expression during HCV/HIV co-infection." J. Interferon Cytokine Res.. 2007;27(4):263-9.
Blackard JT, Kang M, Sherman KE, Koziel MJames, Peters MG, Chung RT. "Effects of HCV treatment on cytokine expression during HCV/HIV coinfection." J. Interferon Cytokine Res.. 2006;26(11):834-8.
Blanchard-Horan C, Stocker V, Moran L, et al. "Examining the challenges and solutions to the implementation of trials in resource-limited settings: Limited Resource Trials." Appl Clin Trials. 2012;21(1):34-42.
Blodget E, Shen C, Aldrovandi G, et al. "Relationship between microbial translocation and endothelial function in HIV infected patients." PLoS ONE. 2012;7(8):e42624.
Boltz VF, Bao Y, Lockman S, et al. "Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP." J. Infect. Dis.. 2014;209(5):703-10.
Boltz VF, Zheng Y, Lockman S, et al. "Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine." Proc. Natl. Acad. Sci. U.S.A.. 2011;108(22):9202-7.
Bosch RJ, Wang R, Vaida F, Lederman MM, Albrecht MA. "Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment." J. Acquir. Immune Defic. Syndr.. 2006;43(4):433-5.
Bosch RJ, Pollard RB, Landay A, Aga E, Fox L, Mitsuyasu R. "Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)." AIDS Res Ther. 2010;7:30.
Bosch RJ, Pollard RB, Landay A, Aga E, Fox L, Mitsuyasu R. "A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment." J. Interferon Cytokine Res.. 2011;31(6):481-3.
Bosch RJ, Bennett K, Collier AC, Zackin R, Benson CA. "Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy." J. Acquir. Immune Defic. Syndr.. 2007;44(3):268-77.
Boswell KL, Paris R, Boritz E, et al. "Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection." PLoS Pathog.. 2014;10(1):e1003853.

Pages